6,949
Participants
Start Date
March 2, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Transfluthrin
Passive emanator with formulated transfluthrin
Placebo
Passive emanator with formulated inert ingredients
Epidemiology Unit, Ministry of Health, Colombo
Clinical Trials Unit, Ragama
S.C. Johnson & Son, Inc.
INDUSTRY
fhiClinical
UNKNOWN
Ministry of Health, Sri Lanka
OTHER_GOV
University of Sri Jayewardenepura, Sri Lanka
UNKNOWN
University of Washington
OTHER
RemediumOne
UNKNOWN
University of Notre Dame
OTHER